Paul Kayne
Company: Palatin Technologies
Job title: Vice President, Biological Sciences
Seminars:
Inflammatory Resolution of Ulcerative Colitis – The Melanocortin System 2:00 pm
Melanocortin agonists don’t block they immune system, they promote resolution of inflammation Animal studies demonstrate the effectiveness and mechanisms of action of these agonists A Phase 2 clinical study showed 33% remission vs 0% placebo and 78% clinical response vs 33% placeboRead more
day: Day Two
Roundtable Discussion: Advancing Autoimmune Therapeutics: Precision Approaches to Inflammation 2:30 pm
Which emerging targets do you see as most promising for transforming the treatment of autoimmune and inflammatory diseases What are the key hurdles to validating novel targets, clinically? Where do you see the most opportunity to combine precision medicine tools (e.g. multi-omics, digital pathology, AI) with new target exploration to drive better outcomes in autoimmune…Read more
day: Day Two
Chair’s Opening Remarks 8:55 am
day: Day Two
Chair’s Closing Remarks 3:30 pm
day: Day Two